HLUN-A:CPH
H Lundbeck A/S Class A
DKKÂ 41.70
arrow_upward
+1.21%(+0.50) 1D
Oct 2, 5:00:00 PM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLUN-A...
Open
DKKÂ 41.25
High
DKKÂ 42.00
Low
DKKÂ 41.05
Mkt. cap
42.70B
Avg. vol.
144.15K
Volume
13.51K
52-wk high
DKKÂ 45.00
52-wk low
DKKÂ 31.40
Shares outstanding
199.15M
No. of employees
5K
Open
DKKÂ 41.25
High
DKKÂ 42.00
Low
DKKÂ 41.05
Mkt. cap
42.70B
Avg. vol.
144.15K
Volume
13.51K
52-wk high
DKKÂ 45.00
52-wk low
DKKÂ 31.40
Shares outstanding
199.15M
No. of employees
5K
News stories
From web sources and news partners
MedWatch
·
2 days ago
Lundbeck seeks to acquire US pharma company Xeris, media says
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOCharl Van Zyl
Employees5K
FoundedAug 14, 1915
Headquarters-
SectorPharmaceutical industry
Websitelundbeck.com